Patents Examined by Kagnew Gebreyesus
  • Patent number: 7335498
    Abstract: The present invention provides a protein having saponin-decomposing activity, more specifically a protein which can decompose a glycoside having soyasapogenol B as an aglycone to produce soyasapogenol B, a polynucleotide encoding such a protein, and a method of producing soyasapogenol B on a large scale using the same. A protein according to the present invention are concerned with (a), (b) or (c), namely (a) a protein comprising an amino acid sequence selected from the group consisting of the amino acid sequences shown in SEQ ID NOs: 2, 4, and 6; (b) a protein that has at least 50% homology to the protein comprising the amino acid sequence of the sequence described in (a) and having saponin-decomposing activity; or (c) a protein comprising a modified amino acid sequence of the sequence described in (a) that has one or more amino acid residues deleted, substituted, inserted, or added and having saponin-decomposing activity.
    Type: Grant
    Filed: August 16, 2006
    Date of Patent: February 26, 2008
    Assignee: Meiji Seika Kaisha, Ltd.
    Inventors: Manabu Watanabe, Naoki Mido, Takayoshi Tamura, Naomi Sumida, Takashi Yaguchi
  • Patent number: 7323321
    Abstract: The present invention is directed towards the fermentative production of amino acids, providing microorganisms, methods and processes useful therefor. Microorganisms of the invention are capable of converting glucose to amino acids other than L-isoleucine, L-leucine and L-valine with greater efficiency than the parent strain. The efficiency of conversion may be quantified by the formula: [(g amino acid produced/g dextrose consumed)*100]=% Yield and expressed as yield from dextrose. The invention provides microorganisms that are made bradytrophic for the synthesis of valine by mutagenesis.
    Type: Grant
    Filed: December 28, 2005
    Date of Patent: January 29, 2008
    Assignee: Archer-Daniels-Midland Company
    Inventors: P. John Rayapati, Corey M. Crafton
  • Patent number: 7297513
    Abstract: A gene encoding glutathione synthetase from Candida utilis is provided and food containing ?-glutamylcysteine cysteine or cystenylglycine is produced by cultivating Candida utilis modified by means of a gene encoding glutathione synthetase under a suitable condition and mixing the obtained culture or a fraction thereof or the culture or a fraction thereof subjected to heat treatment with a raw material of food or drink to process food or drink.
    Type: Grant
    Filed: August 11, 2004
    Date of Patent: November 20, 2007
    Assignee: Ajinomoto Co., Inc.
    Inventors: Hiroaki Nishiuchi, Yasushi Nishimura
  • Patent number: 7294493
    Abstract: The invention relates to the isolation, sequencing, and recombinant expression of genes encoding either a nitrile hydratase (NHase) or amidase (Am) from Comamonas testosteroni 5-MGAM-4D, where the NHase is useful for catalyzing the hydration of nitriles to the corresponding amides, and the amidase is useful for hydrolysis of amides to the corresponding carboxylic acids. Also provided are transformed host cells containing polynucleotides for expressing the nitrile hydratase or amidase enzymes from Comamonas testosteroni 5-MGAM-4D.
    Type: Grant
    Filed: November 16, 2006
    Date of Patent: November 13, 2007
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Mark S. Payne, Robert DiCosimo, John E. Gavagan, Robert D. Fallon
  • Patent number: 7288382
    Abstract: The invention provides methods and compositions for protein structure analysis, including substrate binding sites, sites of protein-protein interactions, three dimensional structure analysis, and stability, all with single amino acid resolution. In general, the subject methods involve introduction of cysteine residues, which serve as probes for physical analysis, into a protein by translational misincorporation in vivo. In many embodiments, proteins containing misincorporated cysteine residues are reacted with a crosslinking agent that covalently links misincorporated cysteine residues to a proximal amino acid in the folded protein. These methods, termed “MXLINK” methods, may be used for protein tertiary structure analysis. In other embodiments, cysteine-misincorporated proteins are used in protein footprinting methods, termed “MPAX” or “MSX” methods.
    Type: Grant
    Filed: March 14, 2003
    Date of Patent: October 30, 2007
    Assignee: The Board of Trustees od the Leland Stanford Junior University
    Inventors: Pehr A. B. Harbury, Joshua A. Silverman, Warham Lance Martin
  • Patent number: 7285406
    Abstract: The invention relates to the isolation, sequencing, and recombinant expression of genes encoding either a nitrile hydratase (NHase) or amidase (Am) from Comamonas testosteroni 5-MGAM-4D, where the NHase is useful for catalyzing the hydration of nitrites to the corresponding amides, and the amidase is useful for hydrolysis of amides to the corresponding carboxylic acids. Also provided are transformed host cells containing polynucleotides for expressing the nitrile hydratase or amidase enzymes from Comamonas testosteroni 5-MGAM-4D.
    Type: Grant
    Filed: November 16, 2006
    Date of Patent: October 23, 2007
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: Mark S. Payne, Robert DiCosimo, John E. Gavagan, Robert D. Fallon
  • Patent number: 7282359
    Abstract: This invention relates to an isolated nucleic acid fragment encoding a 1-deoxy-D-xylulose 5-phosphate reductoisomerase. The invention also relates to the construction of a chimeric gene encoding all or a portion of the 1-deoxy-D-xylulose 5-phosphate reductoisomerase, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the 1-deoxy-D-xylulose 5-phosphate reductoisomerase in a transformed host cell.
    Type: Grant
    Filed: February 28, 2006
    Date of Patent: October 16, 2007
    Assignee: E.I. Dupont de Nemours and Company
    Inventors: Rebecca E. Cahoon, Yong Tao
  • Patent number: 7279290
    Abstract: The present invention provides methods for detecting activation of ATM kinase, DNA damage, and DNA damaging agents. Further provided are antibodies which specifically recognize the phosphorylation state of Ataxia Telangiectasia-Mutated (ATM) kinase. Methods of identifying agents which modulate the activation and activity of ATM kinase are also provided.
    Type: Grant
    Filed: November 23, 2005
    Date of Patent: October 9, 2007
    Assignee: St. Jude Children's Research Hospital
    Inventors: Michael B. Kastan, Christopher Bakkenist
  • Patent number: 7273738
    Abstract: The present invention relates to use of an anti-staling GH-61 polypeptide for preparing an edible product.
    Type: Grant
    Filed: October 1, 2003
    Date of Patent: September 25, 2007
    Assignee: Novozymes A/S
    Inventors: Kirk Matthew Schnorr, Sara Landvik, Tina Spendler, Lars Lehmann Hylling Christensen
  • Patent number: 7255857
    Abstract: Described are methods of treating and preventing conditions associated with a loss of elastic fibers. Also provided herein are methods of screening for agents useful in treating such conditions, and animal models of conditions associated with a loss of elastic fibers.
    Type: Grant
    Filed: September 26, 2005
    Date of Patent: August 14, 2007
    Assignee: Massachusetts Eye & Ear Infirmary
    Inventors: Tiansen Li, Xiaoqing Liu
  • Patent number: 7255856
    Abstract: Described are methods of treating and preventing conditions associated with a loss of elastic fibers. Also provided herein are methods of screening for agents useful in treating such conditions, and animal models of conditions associated with a loss of elastic fibers.
    Type: Grant
    Filed: January 24, 2005
    Date of Patent: August 14, 2007
    Assignee: Massachusetts Eye & Ear Infirmary
    Inventors: Tiansen Li, Xiaoqing Liu
  • Patent number: 7250505
    Abstract: A mammalian homology of Drosophila Disabled protein has been identified and cloned. In particular, the murine homolog designated mDab1 has been cloned and expressed. mDab1, when tyrosine phosphorylated, binds to the SH2 domain of Src, Abl and Fyn. Antibodies specific for mDab1 are provided as are methods for the screening of agents for their ability to modulate mDab1 activity. Methods for diagnosing Disabled protein associated disease are also provided.
    Type: Grant
    Filed: August 21, 1998
    Date of Patent: July 31, 2007
    Assignee: Fred Hutchinson Cancer Research Center
    Inventors: Jonathan A. Cooper, Brian W. Howell
  • Patent number: 7238513
    Abstract: Protein disulfide isomerase is a major component of Conus venom ducts. The invention relates to a protein disulfide isomerase (PDI) from Conus snails, a nucleic acid sequence encoding the Conus protein disulfide isomerase, and to methods for folding disulfide-rich peptides using a protein disulfide isomerase. Oxidative folding of conotoxin precursors, catalyzed by a PDI, was more efficient and decreased the number and concentration of transiently accumulated folding species. The PDI-assisted oxidative folding of conotoxins was also influenced by the propeptide relative to the mature peptide.
    Type: Grant
    Filed: August 31, 2005
    Date of Patent: July 3, 2007
    Assignees: University of Utah Research Foundation, Cognetix, Inc.
    Inventors: Grzegorz Bulaj, Baldomero M. Olivera, Olga Buczek, James E. Garrett, Ian Goodsell
  • Patent number: 7232666
    Abstract: Methanotrophic bacterial strains are provided that have been optimized for the production of carotenoid compounds through the down-regulation of one or more of the crtN1, ald, crtN2 and crtN3 genes of the carotenoid biosynthetic pathway. The resulting strains lack pigmented C30 carotenoid compounds, and show an increase in the production of C40 carotenoids. The use of the optimized host strains for the production of the C40 carotenoids canthaxanthin and astaxanthin is also described.
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: June 19, 2007
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Pamela L. Sharpe, Qiong Cheng, Melissa D. Bosak, Luan Tao, Natalia Sedkova
  • Patent number: 7223543
    Abstract: The present invention relates to a process for the production of conjugated linoleic acid and a process for the production of triglycerides with an increased content of conjugated linoleic acid. Moreover, the invention relates to a nucleic acid sequence; a nucleic acid construct, a vector and transgenic organisms comprising at least one nucleic acid sequence or one nucleic acid construct which encodes a polypeptide with conjugated linoleic isomerase activity. Furthermore, the invention relates to the use of a microorganism of the genus Bifidobacterium as a probiotic.
    Type: Grant
    Filed: June 10, 2002
    Date of Patent: May 29, 2007
    Assignee: Teagasc Dairy Products Research Centre
    Inventors: Catherine Stanton, R. Paul Ross, Oskar Zelder, Bruno Kaesler
  • Patent number: 7223579
    Abstract: The invention relates to an isolated polynucleotide sequence comprising a nucleic acid sequence encoding the amino acid sequence of KshA protein or of KshB protein, encoded by nucleotides 499–1695 of SEQ ID NO: 1 or by nucleotides 387–1427 of SEQ ID NO:2, respectively, and functional homologues thereof. The polynucleotides of the invention can be used to construct genetically modified microorganisms blocked in 3-ketosteroid 9?-hydroxylase activity, which are useful in the microbial degradation of steroids to accumulate certain steroid products.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: May 29, 2007
    Assignee: N.V. Organon
    Inventors: Robert Van Der Geize, Peter Van Der Meijden, Gerda Hessels, Lubbert Dijkhuizen
  • Patent number: 7217809
    Abstract: Methods for making glycoproteins, both in vitro and in vivo, are provided. One method involves incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid. Another method involves incorporating an unnatural amino acid that includes a saccharide moiety into a protein. Proteins made by both methods can be further modified with additional sugars.
    Type: Grant
    Filed: March 29, 2005
    Date of Patent: May 15, 2007
    Assignee: The Scripps Research Institute
    Inventors: Peter G. Schultz, Lei Wang, Zhiwen Zhang
  • Patent number: 7217537
    Abstract: A method to increase carotenoid production in carotenogenic microbial host cells is provided by down-regulating or disrupting glycogen synthesis. Disruption of glycogen synthase activity in a carotenogenic microbial host cell significantly increased carotenoid production. Carotenogenic microorganisms are also provided that have been optimized for the production of carotenoid compounds through the down-regulation and/or disruption of glycogen synthase activity.
    Type: Grant
    Filed: September 15, 2005
    Date of Patent: May 15, 2007
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Edward S. Miller, Jr., James M. Odom, Pamela L. Sharpe
  • Patent number: 7208310
    Abstract: The present invention relates to proteases of high specific activity homologous to proteases derived from Nocardiopsis, and the production thereof by the wild-type, and in recombinant host cells including transgenic plants and non-human transgenic animals. The proteases are effective in animal feed, and detergents. Characteristic structural features of relevance for the specific activity of these proteases of peptidase family S2A or S1E are disclosed.
    Type: Grant
    Filed: June 21, 2004
    Date of Patent: April 24, 2007
    Assignee: Novozymes A/S
    Inventors: Soeren Flensted Lassen, Carsten Sjoholm, Peter Rahbek Ostergaard
  • Patent number: 7205135
    Abstract: Reagents which regulate human adenylate cyclase and reagents which bind to human adenylate cyclase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, peripheral and central nervous system disorders, disorders of the genito-urinary system including but not limited to benign prostatic hyperplasia and urinary incontinence, obesity, COPD and diabetes.
    Type: Grant
    Filed: November 12, 2001
    Date of Patent: April 17, 2007
    Assignee: Bayer HealthCare AG
    Inventor: Zhimin Zhu